Göran Brorson elected chairman of the Biovica board of directors at annual shareholders meeting

At the annual shareholders meeting on the 14th of October, Göran Brorsson was elected as Chairman of the Biovica board of directors. Göran was from July 2000 through January 2015, the CEO of Elos, a medical device company listed on Nasdaq OMX Stockholm. He has also held several management positions in the engineering, processing, and packaging industries.

“In my two years as board member of Biovica I have had the possibility to get to know Biovica from the inside. I am very excited about the progress the company has done in the last couple of years, both with respect to progress of the ongoing clinical studies and the support from EU’s Horizon programme, which granted Biovica EUR 682.000 in research support for the next four years. It will be a most interesting task to lead Biovica’s very competent board of directors and management team in developing the company to a leading position as a companion diagnostics company supporting new innovative drugs for cancer patients.” – Göran Brorsson, Chairman of the Biovica board of Directors

I’m very pleased that Göran has accepted the position as new chairman of the board. His experience and personality will be very valuable for Biovica. I would also like to thank Frank Bertil Johnsson for his engagement and commitment as chairman of the board for the past four years, a period during which Biovica has had a fantastic development.” – Anders Rylander, CEO of Biovica


Biovica is a bio-diagnostic company focused on providing improved diagnostics, predictive data and monitoring of cancer patient under treatment. Biovica has developed DiviTum™, a highly sensitive assay for measuring cell proliferation. Since one of the most fundamental characteristics of cancer is uncontrolled and increased cell growth, DiviTum™ enables valuable prediction capability and monitoring of compounds regulating cell proliferation and the cell cycle. Biovica is ISO 13485 certified for Quality Management Systems and DiviTum™ is CE labeled and MPA registered.


Anders Rylander, CEO
Direct +46 (0) 18 44 44 835
E-mail anders.rylander@biovica.com

Göran Brorsson,Chairman of the Board Biovica

Mobile phone: +46 705 11 78 60

2015-10-16T08:00:41+00:00 October 16th, 2015 08:00|Regulatory|